Product Program year 2019 Source: CMS Open Payments

Quadracel

Drug Vaccines

NDC 49281-562-10

Open in the dashboard

General payments

$131,913

6,226 payments

Research payments

$0

0 payments

Through program year 2019, $131,913 in general payments and $0 in research payments were reported against Quadracel (Vaccines).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

1 row
Year Kind Amount Payments
2019 General $131,913 6,226

Breakdown

Who paid General payments · program year 2019
  1. Sanofi Pasteur Inc. $131,883 6,224 payments
  2. Sanofi-Aventis U.S. LLC $30 2 payments
Top recipients General payments · program year 2019
  1. Steve Kohl San Francisco, CA $15,710 12% · 26 payments
  2. Joseph Domachowske Pediatric Infectious Diseases · Syracuse, NY $3,730 3% · 7 payments
  3. Barbara Pahud Pediatric Infectious Diseases · Kansas City, MO $3,379 3% · 6 payments
  4. Jaime Fergie Pediatric Infectious Diseases · Corpus Christi, TX $2,648 2% · 3 payments
  5. Joseph Christensen Pediatrics · Glen Ellyn, IL $1,586 1% · 3 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2019.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2019
  1. Pediatrics $76,750 69% · 3,476 practitioners
  2. Family Medicine $12,196 11% · 706 practitioners
  3. Pediatric Infectious Diseases Pediatrics $10,427 9% · 7 practitioners
  4. Adolescent Medicine Pediatrics $4,461 4% · 211 practitioners
  5. Internal Medicine $2,770 2% · 160 practitioners

The top 5 of 82 specialties; each share is of general payments naming this product to practitioners with a specialty in 2019. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2019
  1. California $29,240 22% · 562 recipients
  2. New York $14,339 11% · 411 recipients
  3. Texas $8,929 7% · 327 recipients
  4. Illinois $7,284 6% · 230 recipients
  5. Missouri $6,791 5% · 117 recipients

The top 5 of 52 states; each share is of general payments naming this product in 2019 where a state was reported.

The top 25 states, free in the app

6,226 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2019

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record